(Q41639777)

5 October 2017

1 reference

title

Platelet prostanoid receptors (English)

1 reference

5 October 2017

Armstrong RA

1

1 reference

5 October 2017

publication date

1 January 1996

1 reference

Pharmacology & Therapeutics

5 October 2017

published in

1 reference

5 October 2017

volume

72

1 reference

5 October 2017

issue

3

1 reference

5 October 2017

page(s)

171-191

1 reference

Synthesis of prostaglandin D2 and thromboxane B2 by human platelets

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Effect of a hydantoin prostaglandin analogue, BW245C, during oral dosing in man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

On the multiplicity of platelet prostaglandin receptors I. Evaluation of competitive antagonism by aggregometry

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Ligand binding to thromboxane receptors on human platelets: correlation with biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Competitive antagonism at thromboxane receptors in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Inositol 1,4,5-trisphosphate (IP3) induced rapid formation of thromboxane B2 in saponin-permeabilised human platelets: mechanism of IP3 action.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Reconstitution of thromboxane A2 receptor-stimulated phosphoinositide hydrolysis in isolated platelet membranes: involvement of phosphoinositide-specific phospholipase C-beta and GTP-binding protein Gq.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Molecular cloning and characterization of the human prostanoid DP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Anti-peptide antibodies against the human blood platelet thromboxane A2/prostaglandin H2 receptor. Production, purification and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The synthesis of a novel thromboxane receptor antagonist 4(Z)-6-(2-o-chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl) hexenoic acid ICI 192605.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The synthesis of prostaglandin endoperoxide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

A novel inhibitory prostanoid receptor in piglet saphenous vein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Antiplatelet agents in the prevention and therapy of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Chemistry and synthetic development of misoprostol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Desensitization of prostaglandin-activated platelet adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

A direct,stereocontrolled total synthesis of the 9,11-azo analogue of the prostaglandin endoperoxide, PGH2.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

(5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Prostacyclin analogues reduce ADP-ribosylation of the alpha-subunit of the regulatory Gs-protein and diminish adenosine (A2) responsiveness of platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Dual activation of the inositol-triphosphate-calcium and cyclic nucleotide intracellular signaling systems by adrenocorticotropin in rat adrenal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Dual-acting thromboxane receptor antagonist/synthase inhibitors: synthesis and biological properties of [2-substituted-4-(3-pyridyl)-1,3-dioxan-5-yl] alkenoic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

1 reference

7 January 2021

Subcellular distribution of the different platelet proteins phosphorylated on exposure of intact platelets to ionophore A23187 or to prostaglandin E1. Possible role of a membrane phosphopolypeptide in the regulation of calcium-ion transport

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cyclic AMP and platelet prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The biology and pharmacology of PGD2.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

A comparative study of the prostanoid receptor profile of 9α11β-prostaglandin F2 and prostaglandin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cytochemical localization of K(+)-dependent p-nitrophenyl phosphatase and adenylate cyclase by using one-step method in human washed platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Thromboxane A2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Morphine has no direct effect on PGE2-stimulated cyclic AMP production by rat isolated enterocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Regulation of human platelet myosin light chain kinase by the catalytic subunit of cyclic AMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Effects of intravenous infusions of prostaglandin D2 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cloning and expression of cDNA for a human thromboxane A2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Protein-tyrosine phosphorylation and aggregation of intact human platelets by vanadate with H2O2

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Mouse prostaglandin E receptor EP3 subtype mediates calcium signals via Gi in cDNA-transfected Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Prostaglandin D2: a biochemical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

A biphasic effect of prostacyclin (PGI2) on platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Regulation of the intracellular calcium level in human blood platelets: Cyclic adenosine 3′,5′-monophosphate dependent phosphorylation of a 22 000 dalton component in isolated Ca2+-accumulating vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

AH6809, a prostaglandin DP-receptor blocking drug on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Studies on the characterisation of prostanoid receptors: a proposed classification

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cellular activation of thromboxane receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Kinetic studies on stereospecific recognition by the thromboxane A2/prostaglandin H2 receptor of the antagonist, S-145

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cloning of the rat and human prostaglandin F2 alpha receptors and the expression of the rat prostaglandin F2 alpha receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Some biological effects of prostaglandin endoperoxide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Differential inhibition of prostacyclin production and platelet aggregation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Stimulation of human platelet adenylate cyclase by prostaglandin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphenous veins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Mouse thromboxane A2 receptor: cDNA cloning, expression and northern blot analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

1 reference

7 January 2021

Isolation and properties of intermediates in prostaglandin biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cloning of human prostanoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Phorbol esters modulate thrombin-operated calcium mobilisation and dense granule release in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

S-nitroso-glutathione inhibits platelet activation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Effects of EP-receptor subtype specific agonists and other prostanoids on adenylate cyclase activity of duodenal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Evidence for high affinity prostacyclin binding sites in vascular tissue: Radioligand studies with a chemically stable analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Prostaglandins and thromboxanes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

SC-46275: a potent and highly selective agonist at the EP3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Splice variants of the human EP3 receptor for prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Differential activation of Gi and Gs proteins by E- and I-type prostaglandins in membranes from the human erythroleukaemia cell line, HEL

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): 2). Oral activity and efficacy in animal models of arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Effects of single oral dose administration of a hydantoin prostaglandin analogue BW 245C in man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Specific binding sites for prostaglandin D2 on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Prostaglandin D2 inhibits the aggregation of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The eicosanoids and their biochemical mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Counteraction of Calcium-Activated, Phospholipid-Dependent Protein Kinase Activation by Adenosine 3′,5′-Monophosphate and Guanosine 3′,5′-Monophosphate in Platelets1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Systemic availability and abortion-inducing effects of nocloprost after intravenous, subcutaneous and intragastric administration to pregnant guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Intracellular calcium fluxes in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Molecular evolution of receptors for eicosanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Identification and characterisation of a prostacyclin- like receptor in bovine coronary arteries using a specific and stable prostacyclin analogue, ciloprost, as radioactive ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Effects of beraprost on the transmembrane potentials of guinea-pig ventricular muscles during normoxia and hypoxia-reoxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Demonstration of cGMP-dependent protein kinase and cGMP-dependent phosphorylation in cell-free extracts of platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Characterization of partially purified prostaglandin E2 receptor from the canine renal medulla: evidence for physical association of the receptor protein with the inhibitory guanine nucleotide-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Platelet actions of stable carbocyclic analogues of prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

Gastric mucosal binding studies with enprostil: a potent anti-ulcer prostaglandin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900103-9

7 January 2021

10.1016/S0163-7258(96)00103-9

Identifiers

DOI

1 reference

5 October 2017

1 reference